Hepatobiliary Disease Global Clinical Trials Review, H1, 2012GlobalDataApril 25, 2012 64 Pages - SKU: GBDT3871802 |
- Introduction
- Hepatobiliary Disease
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Hepatobiliary Disease
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Pfizer Inc.
- Clinical Trial Overview of Pfizer Inc.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- The University of Tokyo
- Clinical Trial Overview of The University of Tokyo
- Kyoto Prefectural University of Medicine
- Clinical Trial Overview of Kyoto Prefectural University of Medicine
- Teikyo University
- Clinical Trial Overview of Teikyo University
- Osaka Medical College
- Clinical Trial Overview of Osaka Medical College
- Tokyo University of Science
- Clinical Trial Overview of Tokyo University of Science
- Tokyo Medical and Dental University
- Clinical Trial Overview of Tokyo Medical and Dental University
- Nagoya University
- Clinical Trial Overview of Nagoya University
- Hokkaido University Hospital
- Clinical Trial Overview of Hokkaido University Hospital
- Kyushu University
- Clinical Trial Overview of Kyushu University
- Kumamoto University
- Clinical Trial Overview of Kumamoto University
- Chiba University
- Clinical Trial Overview of Chiba University
- Hyogo College Of Medicine
- Clinical Trial Overview of Hyogo College Of Medicine
- Tohoku University
- Clinical Trial Overview of Tohoku University
- Osaka University
- Clinical Trial Overview of Osaka University
- Nagasaki University
- Clinical Trial Overview of Nagasaki University
- University of Nebraska
- Clinical Trial Overview of University of Nebraska
- Kobe University
- Clinical Trial Overview of Kobe University
- Hiroshima University Hospital
- Clinical Trial Overview of Hiroshima University Hospital
- Hokkaido University School of Medicine
- Clinical Trial Overview of Hokkaido University School of Medicine
- University of Michigan
- Clinical Trial Overview of University of Michigan
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, BRIC Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, G7 Countries, 2012*
- Hepatobiliary Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, E7 Countries, 2012*
- Hepatobiliary Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teikyo University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka Medical College, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo University of Science, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012*
- List of Figures
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, E7 Countries (%), 2012*
- Hepatobiliary Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Hepatobiliary Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Clinical Trial Reports
- Inflammatory Pain Global Clinical Trials Review, H1, 2013
- Cancer Pain Global Clinical Trials Review, H1, 2013
- Ascites Global Clinical Trials Review, H1, 2013
- Perspective: StudyOptimizer — Empowering Clinical Trial Enrollment Collaboration at Big Pharma
- Radiculopathy Global Clinical Trials Review, H1, 2013